Extended Data Fig. 3: Number of unique mutations detected for each of 21 paired biopsies from the Prospect-C trial vs. time lapse between BL and PD biopsies.
From: Mutational signatures impact the evolution of anti-EGFR antibody resistance in colorectal cancer
p-value from Spearman’s test. A linear regression line has been added for reference.
